AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,68 $
arrow_downward
-0,70%(-0,21) 1D
29,68 $
0,00% (0,00)
bedtimeAfter hours
Closed: 18 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,57 $
High
30,48 $
Low
29,22 $
Mkt. cap
1,78 մլրդ
Avg. vol.
1,21 մլն
Volume
0,00
52-wk high
44,07 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
Open
29,57 $
High
30,48 $
Low
29,22 $
Mkt. cap
1,78 մլրդ
Avg. vol.
1,21 մլն
Volume
0,00
52-wk high
44,07 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
News stories
From web sources and news partners
Investor's Business Daily
·
1 ժամ առաջ
4 S&P 500 Stocks Paying Plump Dividends Double — And Don't Need AI
24/7 Wall St.
·
1 ժամ առաջ
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
BigGo Finance
·
2 ժամ առաջ
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
JournalArta
·
1 ժամ առաջ
Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc